• CLSI M33-A

CLSI M33-A

Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE

Clinical and Laboratory Standards Institute , 02/01/2004

Publisher: CLSI

File Format: PDF

$138.00$276.01


This document provides a protocol for the performance of the plaque reduction assay for phenotypic antiviral susceptibility testing of herpes simplex virus.

More CLSI Standards PDF

CSA B79.9:22/ASME A112.6.9-2022
CSA A440.2:22/A440.3:22

CSA A440.2:22/A440.3:22

$125.00 $250.00

CSA N285.5-22

CSA N285.5-22

$495.00 $990.00

CSA B79.8:22/ASME A112.6.8-2022